Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure

被引:0
作者
Yogi Umbarawan
Mas Rizky A. A. Syamsunarno
Norimichi Koitabashi
Hideru Obinata
Aiko Yamaguchi
Hirofumi Hanaoka
Takako Hishiki
Noriyo Hayakawa
Motoaki Sano
Hiroaki Sunaga
Hiroki Matsui
Yoshito Tsushima
Makoto Suematsu
Masahiko Kurabayashi
Tatsuya Iso
机构
[1] Gunma University Graduate School of Medicine,Department of Cardiovascular Medicine
[2] Gunma University Graduate School of Medicine,Department of Bioimaging Information Analysis
[3] Gunma University Graduate School of Medicine,Department of Diagnostic Radiology and Nuclear Medicine
[4] Gunma University Graduate School of Health Sciences,Department of Laboratory Sciences
[5] Gunma University Initiative for Advanced Research (GIAR),Research Program for Diagnostic and Molecular Imaging, Division of Integrated Oncology Research
[6] Gunma University Initiative for Advanced Research (GIAR),Department of Biochemistry
[7] Keio University School of Medicine,Clinical and Translational Research Center
[8] Keio University School of Medicine,Department of Cardiology
[9] Keio University School of Medicine,Department of Internal Medicine
[10] Department of Biochemistry and Molecular Biology,undefined
[11] Universitas Padjadjaran,undefined
[12] Faculty of Medicine Universitas Indonesia,undefined
来源
Scientific Reports | / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The energy metabolism of the failing heart is characterized by reduced fatty acid (FA) oxidation and an increase in glucose utilization. However, little is known about how energy metabolism-function relationship is relevant to pathophysiology of heart failure. Recent study showed that the genetic deletion of CD36 (CD36KO), which causes reduction in FA use with an increased reliance on glucose, accelerates the progression from compensated hypertrophy to heart failure. Here, we show the mechanisms by which CD36 deletion accelerates heart failure in response to pressure overload. CD36KO mice exhibited contractile dysfunction and death from heart failure with enhanced cardiac hypertrophy and interstitial fibrosis when they were subjected to transverse aortic constriction (TAC). The pool size in the TCA cycle and levels of high-energy phosphate were significantly reduced in CD36KO-TAC hearts despite an increase in glycolytic flux. De novo synthesis of non-essential amino acids was facilitated in CD36KO-TAC hearts, which could cause a further decline of the pool size. The ingestion of a diet enriched in medium-chain FA improved cardiac dysfunction in CD36KO-TAC hearts. These findings suggest that myocardial FA uptake through CD36 is indispensable for sufficient ATP production and for preventing an increased glycolytic flux-mediated structural remodeling during pressure overload-induced hypertrophy.
引用
收藏
相关论文
共 79 条
  • [1] Ritterhoff J(2017)Metabolism in cardiomyopathy: every substrate matters Cardiovascular research 113 411-421
  • [2] Tian R(2016)Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association Circulation research 118 1659-1701
  • [3] Taegtmeyer H(2013)Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes Circulation research 113 603-616
  • [4] Kolwicz SC(2013)Cardiac metabolism in heart failure: implications beyond ATP production Circulation research 113 709-724
  • [5] Purohit S(2011)Cardiac anaplerosis in health and disease: food for thought Cardiovascular research 90 210-219
  • [6] Tian R(2000)Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle Acta physiologica Scandinavica 168 657-665
  • [7] Doenst T(2009)The Randle cycle revisited: a new head for an old hat American journal of physiology. Endocrinology and metabolism 297 E578-591
  • [8] Nguyen TD(2015)Famine versus feast: understanding the metabolism of tumors Trends Biochem Sci 40 130-140
  • [9] Abel ED(2008)The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell metabolism 7 11-20
  • [10] Des Rosiers C(2010)Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease Physiol Rev 90 367-417